The Asia Pacific Male Infertility Market would witness market growth of 8.9% CAGR during the forecast period (2020-2026).
One of the key causes causing male infertility is sperm heterogeneity of DNA. Male infertility is a heterogeneous group of disorders, known causes account for only 30-50 percent, and unknown cause (idiopathic) is the rest. Infertility affects about 15 percent of people of reproductive age, and the male problem alone involves about 40 percent of the problems.
Tobacco smoke contains approximately 4,000 compounds, like alkaloids, nitrosamines, and inorganic molecules, and some of these are reactive oxygen or nitrogen species. A positive and significant association has been identified between active smoking and sperm DNA fragmentation and also axonemal damage. Smoking is often associated with a decreased sperm count. Smoking is considered to enhance spermatogenesis by increasing the production of norepinephrine, which increases the conversion of testosterone to estrogen causing decreased testosterone levels.
Sperm agglutination refers to the amount of sperm stuck together in the sample given. When evaluating a fertility test result, the percentage assigned to sperm agglutination is the percentage of sperm stuck together in the sample. For example, if the semen sample had only half the sperm sticking together, the report would read only 50 percent sperm agglutination.
Based on Treatment, the market is segmented into Assisted Reproductive Technology & Varicocele Surgery and Medication. Based on Test, the market is segmented into DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay and Other Tests. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Sanofi S.A., Bayer AG, Cadila Healthcare Ltd. (Zydus Cadila), Endo International PLC, Aytu BioScience, Inc., Vitrolife AB, SCSA Diagnostics, Inc., Andrology Solutions Limited, Halotech DNA SL, and Intas Pharmaceutical Ltd.
Scope of the Study
• Assisted Reproductive Technology & Varicocele Surgery and
• DNA Fragmentation Technique
• Oxidative Stress Analysis
• Computer Assisted Semen Analysis
• Microscopic Examination
• Sperm Agglutination
• Sperm Penetration Assay and
• Other Tests
• South Korea
• Rest of Asia Pacific
• Sanofi S.A.
• Bayer AG
• Cadila Healthcare Ltd. (Zydus Cadila)
• Endo International PLC
• Aytu BioScience, Inc.
• Vitrolife AB
• SCSA Diagnostics, Inc.
• Andrology Solutions Limited
• Halotech DNA SL
• Intas Pharmaceutical Ltd.
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Our reports have been used by over 10K customers, including:
The Global Male Infertility Market size is expected to reach $3.2 billion by 2026, rising at a market growth of 7.6% CAGR during the forecast period. Male infertility is the inability of a male to cause pregnancy in a fertile female. A male’s fertility relies mainly on the quantity and quality of their sperms. If a man’s sperm count is small...
Male Infertility Market Research Report by Test (Computer-assisted Semen Analysis, DNA Fragmentation Technique, Microscopic Examination, Oxidative Stress Analysis, and Sperm Agglutination), by Treatment (Assisted Reproductive Technology and Medication) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global...
189 pages •
By Global Industry Analysts
• Jul 2020
Global Kidney Stone Management Devices Market to Reach $1.6 Billion by 2027 Amid the COVID-19 crisis, the global market for Kidney Stone Management Devices estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 3% over the analysis period 2020-2027. Extracorporeal...
The Europe Male Infertility Market would witness market growth of 7.2% CAGR during the forecast period (2020-2026). Elements of adult and gender identity can never be realized in infertile individuals due to the loss of pregnancy, childbirth, and lack of family and generational continuity and inclusiveness within their wider community....
The Latin America, Middle East and Africa Male Infertility Market would witness market growth of 8.5% CAGR during the forecast period (2020-2026). Elements of adult and gender identity can never be realized in infertile individuals due to the loss of pregnancy, childbirth, and lack of family and generational continuity and inclusiveness...
Continuous Renal Replacement Therapy Market Research Report by Product (Bloodline Sets, Dialysates and Replacement Fluids, Disposables, Hemofilters, and Systems), by Therapy (Non-renal and Renal), by Modality, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Continuous Renal Replacement...
‘Complement 3 Glomerulopathy (C3G) - Epidemiology Forecast – 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Complement 3 Glomerulopathy (C3G) epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Complement 3 Glomerulopathy (C3G) Understanding The...
Vasectomy Market Research Report by Drug (Anesthetics, Antibiotics, and Painkillers), by Type (Conventional, Minimally Invasive, and No-Scalpel), by Patient, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Vasectomy Market is expected to grow from USD 14,763.66 Million in 2019 to USD...
Nephrology Devices Market Research Report by Device (Dialysis Catheter, Dialysis Instrument, Lithotripter, and Hemodialysis Water Treatment System) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Nephrology Devices Market is expected to grow from USD 11,952.37 Million in 2019 to USD 17,226.74 Million...
The North America Laser Therapy Market is projected to reach US$ 669.92 million by 2027 from US$ 1,441.45 million in 2019. The market is estimated to grow at CAGR of 10.2% from 2020 to 2027. The growth of the market is driven by the factors such as, broad medical applications, and growing product launches. However, the market is likely...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.